<DOC>
	<DOCNO>NCT02867358</DOCNO>
	<brief_summary>The purpose study investigate clinical efficacy KT07 capsule alleviation fever symptom include nasal congestion , sore throat , cough , ache pain , fatigue , headache , chill sweat subject acute uncomplicated influenza .</brief_summary>
	<brief_title>A Clinical Trial KT07 Capsule U.S.A</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<criteria>1 . Subjects mild moderate acute uncomplicated influenza , oral temperature 37.339.3℃ ( 99.1102.8° F ) ; plus least one respiratory symptom ( nasal congestion , sore throat cough ) ; least one constitutional symptom ( ache pain , fatigue , headache chill sweat ) . 2 . Subjects recently expose patient infected influenza virus without rapid influenza diagnostic test ( RIDT ) confirm influenza infection ( influenza virus A B infection ) . 3 . Onset symptoms less 48 hour Visit 1 ( Screening ; study drug administration visit ) receive antiviral/antiinfluenza medication . 4 . Age 18 50 year old . 5 . Subjects able understand willing sign inform consent form ( ICF ) . 6 . All female subject must negative urine pregnancy test result . All female subject male subject spouse/partner must agree use medically acceptable method contraception throughout entire study period 30 day female 90 day male subject study drug discontinuation . 1 . Subjects suffer severe influenza oral temperature 39.3℃ ( 102.8°F ) without symptom . 2 . Subjects follow documented condition : low respiratory tract infection influenza , asthma require daily therapy , include acute flare chronic asthma bronchial asthma , chronic obstructive pulmonary disease ( COPD ) , acute infectious disease , chronic respiratory disease , bacterial infection respiratory system , : suppurative tonsillitis , acute tracheobronchitis , sinusitis , otitis ; subject history moderate severe cardiac , hepatic , renal hematopoietic disorder , bleed tendency hemorrhagic disease , mental neurological system disease ; subject hypertension , diabetes , hyperthyroidism increase intraocular pressure ; subject cancer . 3 . Subjects anatomical nasal obstruction gross anatomical abnormality . For example , nasal polyp significant nasal septal deviation . 4 . Subjects take medication treatment influenza related symptom , include limited antipyretic analgesic medicine , antibiotic , antiviral drug . 5 . Subjects acute dyspnea , wheeze , moist rale screen examination . 6 . Clinically excessively obese subject BMI≥40 . 7 . Alcoholism substance abuse history . 8 . Subjects receive influenza vaccine within 6 month . 9 . Participation clinical trial within 1 month . 10 . Pregnant breastfeeding female subject 11 . Allergy know allergy component study medication . 12 . Allergy aspirin nonsteroid antiinflammatory drug ( NSAIDs ) , ibuprofen . 13 . Subjects receive antipyretic and/or analgesic medication condition influenza back pain prior randomization . 14 . Administration immunomodulators , interferon inducer , homeopathic , hormonal hormone replacement therapy , antiviral antibacterial drug last 4 week first dose . 15 . Any associated disease condition , opinion investigator , might restrict impede participation study affect study result .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>acute uncomplicated influenza</keyword>
</DOC>